Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 1

1(20.0%)

5Total

N/A(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01094574Not ApplicableCompleted

Evaluation of Propranolol's Effect on Pain and Inflammation.

Role: lead

NCT00672438Not ApplicableCompleted

Heritability of Opioid Effects: A Twin Study

Role: lead

NCT01885728Not ApplicableCompleted

Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients

Role: lead

NCT01882569Completed

Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery

Role: lead

NCT01882582Completed

Evaluation of Immune Signaling Networks in Healthy Human Volunteers

Role: lead

NCT01578798Completed

Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

Role: lead

NCT01097902Phase 1Completed

Study of Experimental Models of Pain and Inflammation.

Role: lead

NCT00186563Not ApplicableCompleted

A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers

Role: lead

All 8 trials loaded